AMAG Pharmaceuticals
AMAG
AMAG was delisted on the 13th of November, 2020.
96 hedge funds and large institutions have $455M invested in AMAG Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 96 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
213% more call options, than puts
Call options by funds: $926K | Put options by funds: $296K
Top Buyers
Top Sellers
AMAG Hedge Fund Activity: Q2 2013 in Review
96 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q2 2013, worth a combined $455M.
Buyers outnumbered sellers: 96 funds opened new AMAG positions and 0 closed out — a net gain of 96 holders — while 0 added to existing stakes and 0 trimmed.
- 96 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $455M of AMAG Pharmaceuticals stock for Q2 2013.
- 96 funds opened new AMAG Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +96 holders.
Based on aggregated 13F filings for Q2 2013.